Gujarat Inject Kerala Ltd manufactures pharmaceutical productsBusiness Overview: Company is jointly promoted by Kerala State Industrial Development Corporation Limited, a wholly owned subsidiary of Government of Kerala and Gujarat Inject Limited. Company manufactures and sells bulk drugs, formulations, chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non...
The company's Board has appointed Mr. Rushiraj Zaverbhai Patel and Mr. Nileshbhai V. Rangholiya as Additional Independent Directors for five years. Mr. Dipak Diwan has also been appointed as an Additional Executive Director for five years and as Chief Financial Officer. This revised announcement confirms Mr. Diwan's CFO role is...
Gujarat Inject Kerala Limited has announced significant changes in its leadership, with two Non-Executive Independent Directors, Mr. Gautam Keshavlal Chauhan and Mr. Narayansinh Chauhan, resigning from their positions. Additionally, Mr. Murli Shivshankaran Nair has resigned as the Chief Financial Officer. All departures are effective as of the close of business...
Gujarat Inject Kerala Limited has announced a board meeting to appoint three new directors, subject to shareholder approval. Mr. Rushiraj Zaverbhai Patel and Mr. Nileshbhai V. Rangholiya join as Independent Directors for five years. Mr. Dipak Diwan is appointed as Executive Director and Chief Financial Officer for five years. Rushiraj...
Gujarat Inject Kerala Limited has announced a board meeting to discuss the purchase of solar units from Soleos Energy Private Limited through an Investment Sale agreement. The company holds no shares in Soleos, and the transaction involves no special rights or related party concerns. This acquisition marks a strategic entry...
Gujarat Inject Kerala Limited submitted its Annual Secretarial Compliance Report for FY 2024-25, confirming adherence to all applicable regulations except a delay in appointing a Company Secretary and Compliance Officer, for which the company was fined ₹82,600. The appointment was regularized on June 10, 2024. The report found no other...
